Charles Y. Lin, Senior VP, RESEARCH & DEVELOPMENT at Kronos Bio, Inc. (KRON), sold 12,036 shares at $1.05 ($13K) on 2024-02-21, disclosed to the SEC on 2024-02-23.
Open-market sale of $13k KRON by Senior VP, RESEARCH & DEVELOPMENT. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.